PRESS RELEASE: IVI Appoints Dr. Richard Chapman as Chief Science Officer
Alexandria, VA — January 26, 2021 — The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — today announced that Rick Chapman, PhD, will be its next Chief Science Officer. Chapman, who is currently Director of Health Economics at the Institute […]
Partnering for Patient-Centricity
In a commentary published in the American Journal of Managed Care, IVI’s Jennifer Bright, EveryLife Foundation’s Annie Kennedy, and National Health Council’s Eleanor Perfetto teamed up to describe how their organizations are joining forces to advance patient-centric value assessment measurements. “Patient centricity” — engaging with patients as partners, rather than doing on behalf of the […]
How to Strengthen Value Assessment’s Tool Box
With attention increasingly focused on the Biden Administration’s new interest in a German-style panel to determine fair healthcare pricing, Jennifer Bright says we’re at a crucial time to be absolutely clear about value – and how to measure it with patients’ perspectives fully represented. Read about IVI’s principles for HTA in the US on the […]
Patients at IVI of It All
Making our way through a global pandemic will require all the assets and brain power our health system and leaders have to offer. And yet while the pandemic has been a novel disruptor, it has also served to highlight the problems our system has experienced for years, even decades. Whether we are discussing COVID-19 or […]
How do we identify and measure value for patients with rare diseases?
Authors: Annie Kennedy and Joff Masukawa. Rare diseases impact 1 in 10 Americans, and over 400 million people worldwide. The current development and FDA approval process can cost hundreds of millions of dollars – and take an average of 15 years – to develop one therapy. For the 30% of children diagnosed with a rare […]
Exploring Patient Heterogeneity and Diversity in Treatment Responses
Author: Jennifer Bright, MPA Everyone hopes for a COVID vaccine so our lives can return to normal. Yet, we know that even if clinical trials prove a vaccine’s effectiveness, our society will still have to endure a long process of distribution. I’m personally willing to wait for a vaccine for healthcare workers, the elderly, and […]
Tackling Hard Questions in Value
Author: Jennifer Bright, MPA, Executive Director, IVI For decades, we’ve known that untreated or poorly treated Major Depressive Disorder (MDD) is an enormous burden on individual patients, our health care system, and our society. Despite having this knowledge, there is much work to do in order to support and optimize cost-effective care for patients suffering […]
Measuring Value: COVID-19 Forces a Reassessment
Authors: Patricia Deverka, Jennifer Bright, Louis Garrison, Samuel Nussbaum We have seen the COVID-19 pandemic decimate people’s lives, health care systems, and the global and US economy, with investments by the US government exceeding $4 trillion dollars and with unemployment approaching 20%. In recent days, numerous articles have speculated on the pricing for Gilead’s new […]
Looking Ahead to 2021: Let’s Really Make 2021 the Year of the Patient
Author: Jennifer Bright, MPA, Executive Director, IVI The promise of a new year offers an opportunity to recall our best moments in 2020 (surely there are a few!) and get excited for what’s ahead. For IVI, I’ve been thinking about the accomplishments not just in 2020, but in the three years since I joined this […]
Defining Value Starts with Patients
Authors: Alan Balch and Donna Cryer The vast majority of experts agree that we could, and should, be doing a lot more to include input from patients in value assessment, from conceptualization to data inputs to implementation. The crux of the problem is that in today’s world, we end up with models that assign a […]